Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC310911 in treatment-naive HIV-1 infection
NCT00838162Phase 2Completed
- Sponsor
- Tibotec
- Start
- Jun 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TMC-310911 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Jun 2009; status: completed.
02
Drugs
TMC-310911
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00838162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838162.